Citation Impact
Citing Papers
Reliability of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry in Breast Core Needle Biopsies
2010
Breast cancer
2019 Standout
Oncogenes and Male Breast Carcinoma: c-erbB-2 and p53 Coexpression Predicts a Poor Survival
2000
Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study
2010
Digital Image Analysis Improves the Quality of Subjective HER-2 Expression Scoring in Breast Cancer
2008
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Prognostic models for breast cancer: a systematic review
2019
Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
2010
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer
2007
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Breast cancer statistics, 2019
2019 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Prognostic Factors in Non-small Cell Lung Cancer
2002
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
2000 Standout
Review article: the role of butyrate on colonic function
2007 Standout
Cancer to bone: a fatal attraction
2011 Standout
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer
2001
Wound repair and regeneration
2008 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
Cushing's syndrome
2015 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The Thrombospondins
2011 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Breast core needle biopsy: issues and controversies
2010
Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1997
Molecular mechanisms of cisplatin resistance
2011 Standout
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
2006
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Reading the prognosis of the individual with breast cancer
2007
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Corticotroph carcinoma of the pituitary: a clinicopathological study
2002
A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
2011 StandoutNature
The Effect of Thrombospondin-1 and TGF-β1 on Pancreatic Cancer Cell Invasion
1998
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Receipt of locoregional therapy among young women with breast cancer
2012
The 17q12-q21 amplicon: Her2 and topoisomerase-IIα and their importance to the biology of solid tumours
2006
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
IgG4-related disease
2014 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Ki67 expression in breast cancer
2016 Standout
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
2009
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds
2004
Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
1994 Standout
Breast cancer metastasis: markers and models
2005 Standout
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
2008
Overall survival according to type of surgery in young (≤40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
2015
Crystalloid Inclusions in Endothelial Cells of Cellular and Capillary Hemangiomas
1983
Role Of Cell Association In Virus Infection And Virus Rescue
1970
The Cellular and Molecular Biology of RNA Tumor Viruses, Especially Avian Leukosis-Sarcoma Viruses, and Their Relatives
1974 StandoutNobel
Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies.
1993 StandoutNobel
Lung Tumors in Mice: Application to Carcinogenesis Bioassay
1975
Breast Cancer Statistics, 2022
2022 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Aspects Of The Eb Virus
1970
Pericardial Disease in Pregnancy
2003
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
VIRUS‐LIKE PARTICLES IN ROUS RAT SARCOMA
1968
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Carcinogenesis by RNA sarcoma viruses
1970 StandoutNobel
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
Investigations on Virus Production in RSV Mammalian Tumours
1970
Cancer treatment and survivorship statistics, 2016
2016 Standout
Association of uPA, PAI-1, and uPAR in Nipple Aspirate Fluid (NAF) with Breast Cancer
2003
ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology
1998
Ribonuclease-Sensitive Deoxyribonucleic Acid Polymerase Activity in Uninfected Rat Cells and Rat Cells Infected with Rous Sarcoma Virus
1971 StandoutNobel
Cancer treatment and survivorship statistics, 2019
2019 Standout
Re‐exposure of human lymphoblastoid cell lines to Epstein‐Barr virus
1972 StandoutNobel
Fibrohistiocytic Tumors and Related Neoplasms in Children and Adolescents
2012
When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer
2001
Plasmin/Plasminogen System in Colorectal Cancer
2002
Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.
1975 Standout
A Spontaneous Lower Motor Neuron Disease Apparently Caused by Indigenous Type-C RNA Virus in Wild Mice2
1973
Hybridization of Rous Sarcoma Virus Deoxyribonucleic Acid Polymerase Product and Ribonucleic Acids from Chicken and Rat Cells Infected with Rous Sarcoma Virus
1972 StandoutNobel
Carcinogenic Nitroso Compounds
1967 Standout
Breast Cancer in Men
2002 Standout
Works of E Bucciarelli being referenced
Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
1997
Biopathologic profile of breast cancer core biopsy: is it always a valid method?
2004
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization.
2006
Breast cancer in young women: clinicopathological features and biological specificity
2003
C-Type Particles in Primary and Transplanted Lung Tumors Induced in BALB/c Mice by Hydrazine Sulfate: Electron Microscopic and Immunodiffusion Studies<xref ref-type="fn" rid="FN1">2</xref>
1972
HER2 Overexpression as a Predictive Marker in a Randomized Trial Comparing Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil with Epirubicin in Patients with Stage I/II Breast Cancer: Long-Term Results
2005
Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes
2003
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer
2002
Spontaneous Dissecting Aneurysm of Coronary Artery in a Pregnant Woman at Term
1998
DNA-ploidy studies on cytological preparations from breast cancers by image analysis: Comparison with feulgen staining performed in destained Papanicolaou slides
1996
Biological prognostic factors for early stage completely resected non-small cell lung cancer
2000
Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues
1996
CD30+ anaplastic large‐cell lymphoma, null type, with signet‐ring appearance
1997
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro
2006
Giant Cell Tumor of Tendon Sheath: Immunohistochemical Study of 20 Cases
1997
Presence of particles with the morphology of viruses of the avion leukosis complex in meningeal tumors induced in dogs by Rous sarcoma virus
1966
C-ERB-B2 expression as a predictor of outcome in a randomized trial comparing adjuvant CMF vs single-agent epirubicin in stage I-II breast cancer (BC) patients
1999
Ultrastructure of Meningeal Tumors Induced in Dogs With Rous Sarcoma Virus
1967
Induction of Hepatomas in CBA/Cb/Se Mice by Hydrazine Sulphate and the Lack of Effect of Croton Oil on Tumour Induction in BALB/c/Cb/Se Mice
1964